Clinical Trial: Elevated Rate Pacing of Cardiac Amyloidosis

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583823) titled 'Elevated Rate Pacing of Cardiac Amyloidosis' on May 06.

Brief Summary: This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preexisting pacemakers.

Study Start Date: Oct. 10, 2025

Study Type: INTERVENTIONAL

Condition: Cardiac Amyloidosis Pacemaker

Intervention: OTHER: Pacemaker Rate

CA clinic patients with pacemakers will receive a personalized pacing protocol individual to their height and left ventricular ejection fraction.

Recruitment Status: RECRUITING

Sponsor: University of Minnes...